Table 1

Baseline data

VariableMean (±SD) number (%)
Age, years67.9 (±11.4)
Gender
 Male32 (65.3%)
 Female17 (34.7%)
BMI, kg/m229.1 (±5.8)
Previous CVA2 (4.1%)
Peripheral vascular disease4 (8.2%)
Non-cardiac surgery2 (4.1%)
Previous MI23 (46.9%)
Previous CABG11 (22.4%)
Previous PCI24 (29%)
Diabetes
 Not diabetic27 (55.1)
 Diet controlled1 (2)
 Oral medicine12 (24.5)
 Insulin dependent9 (18.4%)
Clinical syndrome
Stable angina25 (50%)
UA/NSTEMI17 (34%)
STEMI8 (16%)
Cardiogenic shock
(consequence of STEMI)
3 (6%)
Target vessel
LMS/LAD21 (42%)
LCX/RCA26 (52%)
SVG3 (6%)
Procedure urgency
 Elective23 (46%)
 Urgent19 (38%)
 Emergency8 (16%)
LV function
 Good (EF >50%)31 (63.3)
 Moderate (EF 30%–50%)8 (16.3)
 Poor (EF <30%)4 (8.2)
 Unknown6 (12.2)
Diagnostic devices
 None38 (76%)
 IVUS/OCT7 (14%)
 Pressure wire2 (4%)
Procedural indications
Heavily calcified lesion22 (44%)
CTO (failure to cross)10 (20%)
High thrombus burden11 (22%)
In-stent restenosis7 (14%)
6 Fr guide catheter41 (82%)
Arterial access
Radial (right/left)30 (60%)
Femoral16 (32%)
Combined (radial/femoral)4 (8%)
Glycoprotein IIb/IIIa (eptifibatide)8 (16%)
  • BMI, body mass index; CABG, coronary artery bypass grafting; CTO, chronic total occlusion; EF, ejection fraction; IVUS, intravascular ultrasound; LAD, left anterior descending artery; LCX, left cercumflex artery; LMS, left main stem; LV, left ventricle; MI, myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; OCT, optical coherence tomography; PCI, percutaneous coronary intervention; RCA, right coronary artery; STEMI, ST-elevation myocardial infarction; SVG, saphenous vein grafts; UA, unstable angina.